|
|||||
|
|
Erratum to: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma |
|
| Authors: | Shinsuke Iida Takaaki Chou Shinichiro Okamoto Hirokazu Nagai Kiyohiko Hatake Hirokazu Murakami Toshiyuki Takagi Kazuyuki Shimizu Henry Lau Kenichi Takeshita Masaaki Takatoku Tomomitsu Hotta |
| Affiliation: | 1. Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan 2. Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan 3. Division of Hematology, Keio University School of Medicine, Tokyo, Japan 4. National Hospital Organization Nagoya Medical Center, Nagoya, Japan 5. Cancer Institute Hospital, Tokyo, Japan 6. School of Health Sciences, Faculty of Medicine, Gunma University, Maebashi, Japan 7. Kimitsu Chuo Hospital, Kisarazu, Japan 8. Nagoya City Midori General Hospital, Nagoya, Japan 9. Celgene Corporation, Summit, USA 10. Celgene KK, Tokyo, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |